Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration

计划入组 37 人 · 首次发布于 2020 年 2 月 17 日

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

计划入组 32 人 · 首次发布于 2010 年 3 月 15 日

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

计划入组 20 人 · 首次发布于 2007 年 7 月 18 日

undisclosed tyrosine kinase inhibitor (Durasert, wet age-related macular degeneration)

RAGE-immunoglobulin fusion protein (diabetes/Dry and Wet age related macular degeneration/Covid-19)

Pegaptanib

Optiva Inc

Australia

Ocugen

United States

NEW AGE VENTURES LLC

United States

FDA Approves First CRISPR-Cas13 RNA Editing Trial for Wet Age-Related Macular Degeneration

Merck Initiates Pivotal Phase 2b/3 Trial for Novel Bispecific Antibody MK-8748 in Wet Age-Related Macular Degeneration

UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration